Acelrx Pharmaceuticals Inc. buy tamam
Start price
23.10.18
/
50%
€70.72
Target price
23.04.19
€131.69
Performance (%)
-13.27%
End price
23.04.19
€61.34
Summary
This prediction ended on 23.04.19 with a price of €61.34. The prediction for Acelrx Pharmaceuticals Inc. disappointed with a performance of -13.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | -8.123% | -8.123% | 12.137% | -60.267% |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by tamam for this prediction
In the thread Acelrx Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von stratec zu
tamam stimmt am 23.10.2018 der Buy-Einschätzung von stratec mit dem Kursziel 7,3$ zu.
Überschrift: ACRX PDUFA action date November 3, 2018, for sufentanil for the management of moderate-to-severe pain
(Laufzeit überschritten)
Stopped prediction by tamam for Acelrx Pharmaceuticals Inc.
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€65.49
24.04.19
24.04.19
€117.26
04.11.21
04.11.21
-77.63%
05.11.21
05.11.21
